Picture of Vitrolife AB logo

VITR — Vitrolife AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeMid CapMomentum Trap

Brief: Vitrolife Q4 EBITDA Up At SEK 160 Mln

Feb 6 (Reuters) - Vitrolife AB  VITR.ST :
    * REPORT ON OPERATIONS 2019: HIGH TIME-LAPSE GROWTH
    * VITROLIFE AB - Q4 SALES SEK 409 MILLION VERSUS SEK 320
MILLION
YEAR AGO
    * VITROLIFE AB - Q4 SALES SEK BOARD PROPOSES A DIVIDEND OF
SEK 114
(92) MILLION, CORRESPONDING TO SEK 1.05 (0.85) PER SHARE.
MILLION VERSUS SEK 320 MILLION YEAR AGO
    * VITROLIFE AB - Q4 OPERATING INCOME BEFORE DEPRECIATION AND
AMORTISATION (EBITDA) AMOUNTED TO SEK 160 (135) MILLION,
CORRESPONDING TO A MARGIN OF 39 (42) PERCENT.

Source text for Eikon:  ID:nWkr5CKGXS 
Further company coverage:  VITR.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))

Recent news on Vitrolife AB

See all news